Market Research Logo

Blood Plasma: Market Shares, Strategies, and Forecasts, Worldwide, 2018 to 2024

Blood Plasma: Market Shares, Strategies, and Forecasts, Worldwide, 2018 to 2024

WinterGreen Research announces that it has published a new study Blood Plasma: Market Shares, Strategy, and Forecasts, Worldwide, 2018 to 2024. The 2018 study has 338 pages, 148 tables and figures. Worldwide markets are poised to achieve continuing growth as animal and human blood is further fractionated to address more disease treatments and becomes more effective in the research and development aspects of medical care delivery.

Blood is for most species the essence of life. Blood plasma provides significant health benefits. The varieties of proteins and other components of blood are in demand worldwide. Blood proves its value by managing a variety of ways to treat disease.

The plasma proteins or derivatives in blood are extracted via the fractionation process. A range of valuable products are manufactured from blood plasma through fractionation. Fractionation occurs in tanks at near freezing temperatures. Fractionation is used to maintain the integrity of the proteins in plasma. This process includes a phase of introducing various viral inactivation procedures.

Blood plasma offers high value for its volume and weight. One refrigerated container might be worth more than an entire shipload of grain. Blood provides significant health benefits to people. Blood exports boost U.S. exports with minimal carbon emissions.

Liver disease is a major cause of illness and death worldwide. In China, 400 million people have liver diseases, primarily viral hepatitis (predominantly hepatitis B virus [HBV]). Nonalcoholic fatty liver disease and alcoholic liver diseases are also prevalent diagnoses.

The blood plasma market is driven in part by China, and by demand from China for high quality blood from the US. Chinese patients consumed 400 metric tons of serum albumin in 2017, half of the global total of that blood protein. The necessary supply could be provided by the Chinese population, but, many of them are afraid to donate blood.

The reason is a well-remembered 1990s health scare in which tens of thousands of farmers who had been paid to donate blood acquired HIV from unsanitary needles. The ensuing scandal was covered up by the government.

As a result, China has to import about 60% of its serum albumin—and the ever-rising demand has driven up prices. American companies have an edge in the Chinese markets because of the quality of the blood collected. The edge is apparent in the fact that three foreign companies account for 88% of China’s serum albumin imports.

The billion-dollar market for blood worldwide has a variety of participants. Thermo Fsher Scientific has the largest market participation. Sales of blood therapeutics were $30.9 billion in 2017. By 2024, these products reach $57.5 billion, reflecting a five-year CAGR of 8.2%.


  • Blood Executive Summary
    • Blood Market Research Executive Summary
    • Blood Market Shares
  • Blood: Market Description And Market Dynamics
    • Blood Plasma
      • Immunotherapy Plus Chemotherapy
    • Liver Disease Is A Major Cause Of Illness And Death In China
      • Fractionation Technique for Manufacture Blood Products from Plasma: Treatment for Chronic Hepatitis B Infection
    • Plasma Products Market Trends
  • Blood Market Shares And Forecasts
    • Blood Market Driving Forces
    • Serum (Blood) Market Shares
      • Table Blood Plasma Market Shares, Dollars, Worldwide, 2017
      • Table Blood Plasma Market Shares Units, Worldwide, 2017
      • Blood Serum Providers To China, Market Shares,
        • Table Blood Serum Providers To China, Market Shares, Dollars, Worldwide, 2017
      • Blood Company Descriptions
      • Blood Company Descriptions
      • Intense Competition Comes From Local And Overseas Pharmaceutical Enterprises in China
      • 30 Approved Manufacturers Of Plasma Products in China
      • Major Competitors in China
    • Serum (Blood) Market Forecasts
      • Table Blood Market Forecasts, Dollars, Worldwide, 2018-2024
      • Blood Market Segments
      • Transpacific Trade In Human Blood Plasma Products
      • Tons of Blood Plasma
        • Table Blood Plasma Collection Production, Selected Companies, Tons, Worldwide, 2017
        • Table Blood Plasma Collection Production, Regional Analysis, Tons, Worldwide, 2017
    • Serum (Blood) Market Segment Forecasts
      • Blood Plasma Protein Treatment Market Segments, Albumin, Polyvalient IVIG/SCIG, Factor X, Factor VIII, Huperimunes
        • Table Blood Plasma Proteins Market Segments, Albumin, Polyvalient IVIG/SCIG, Factor X, Factor VIII, Huperimunes, Dollars and Percent, Worldwide, 2017
        • Table Blood Plasma Proteins Market Segments, Albumin, Polyvalient IVIG/SCIG, Factor X, Factor VIII, Huperimunes, Dollars and Percent, Worldwide, 2012
        • Table Blood Plasma Proteins Market Forecasts, Dollars, Worldwide, 2018- 2024
        • Table Blood Plasma Protein Treatment Market Segments, Albumin, Polyvalient IVIG/SCIG, Factor X, Factor VIII, Huperimunes, Dollars, Worldwide, 2018-2024
        • Table Blood Plasma Protein Treatment Market Segments, Albumin, Polyvalient IVIG/SCIG, Factor X, Factor VIII, Huperimunes, Percent, Worldwide, 2018-2024
      • IgG
      • Blood Immunoglobulin Segment
        • Table Immunoglobin Blood Market Segment Forecasts, Dollars and Percent Worldwide, 2018-2024
      • Blood Market Segment Forecasts, Immunology, Pulmonology, Oncology, Rheumatology, Neurology, Hematology, Transplants and Other Applications
        • Table Blood Market Segment Forecasts, Immunology, Pulmonology, Oncology, Rheumatology, Neurology, Hematology, Transplants and Other Applications, Forecasts, Dollars, Worldwide, 2018-2024
        • Table Blood Market Segment Forecasts, Immunology, Pulmonology, Oncology, Rheumatology, Neurology, Hematology, Transplants and Other Applications, Forecasts, Percent, Worldwide, 2018-2024
      • Blood Market Segment Forecasts, Disease Treatment, Cell Culture, Medical Device and Scientific Research
        • Table Blood Market Segment Forecasts, Disease Treatment, Cell Culture, Medical Device and Scientific Research, Dollars, Worldwide, 2018-2024
        • Table Blood Market Segment Forecasts, Cell Culture, Medical Device and Scientific Research. Percent, Worldwide, 2018-2024
      • Blood Market Segment Forecasts, Immunology, Pulmonology, Oncology, Rheumatology, Neurology, Hematology, Transplants and Other Applications
        • Table Blood Market Segment Forecasts, Immunology, Pulmonology, Oncology, Rheumatology, Neurology, Hematology, Transplants and Other Applications, Forecasts, Dollars, Worldwide, 2018-2024
        • Table Blood Market Segment Forecasts, Immunology, Pulmonology, Oncology, Rheumatology, Neurology, Hematology, Transplants and Other Applications, Forecasts, Percent, Worldwide, 2018-2024
      • Blood Market Is Segmented By Application
    • Animal and Bovine Serum Market Segments, FBS, ABS, NBCS, BS, Porcine Sera, Dollars, Worldwide, 2017
      • Table Animal and Bovine Serum Market Segments, FBS, ABS, NBCS, BS, Porcine Sera, Dollars, Worldwide, 2017
      • Plasma Proteins Market
      • Plasma Proteins Chinese Market
        • Table Blood Plasma and Serum Providers To China, Market Shares, Dollars, Worldwide, 2017
        • Table Blood Plasma and Serum Providers To China Description, 2017
        • Table Blood Plasma Proteins Market Segments, Albumin, Polyvalient IVIG/SCIG, Factor X, Factor VIII, Huperimunes, Dollars and Percent, Worldwide, 2017
        • Table Blood Plasma Proteins Market Segments, Albumin, Polyvalient IVIG/SCIG, Factor X, Factor VIII, Huperimunes, Dollars and Percent, Worldwide, 2012
      • Blood Basic Proteins Market Prospects
      • Global Plasma Supply For Fractionation And The Role of the United States
      • Hep B Treatments
      • Applications For Processed Bovine Serum
      • FBS
      • FBS Cell Culture Process Of Growing Cells Under Controlled Conditions In Vitro
      • ABS
      • Newborn Calf Serum NBCS
      • BCS
      • Porcine Sera
      • Biotechnology Industry
      • Global Animal Health Market
    • Serum (Blood) Prices
      • Corning Bolvine Serum
      • Millipore / Sigma Aldrich Fetal Bovine Serum, FBS, FCS, Sera,
      • Prices of Pharmaceutical Plasma Products
    • Serum (Blood) Regional Market
      • Table Blood Regional Market Segments, 2017
      • US
      • China
      • Chinese Clinical Approval For Human Blood Coagulation Factor VIII
      • Blood Plasma and Serum Providers Improved Fractionation Technologies for China Market, 2017
      • Blood Plasma and Serum Providers Increasing Market Concentration of Top Players China Market, 2017
      • China Mutual Aid Blood Donation
      • China Cord Blood Market For Cord Blood Banking
      • Reimbursement in China
      • Asia-Pacific
      • Europe
      • Australia
      • Company Geographical Revenue
        • Table Thermo Fisher Scientific Revenues, United States, China, Other, Consolidated revenues
  • Serum (Blood) Product Descripion
    • Plasma Source of Life
      • Plasma Major Component Of Blood
      • Plasma Carrier For Nutrients, Hormones, Proteins
    • Plasma Vital To The Regulation Of Body Functions
      • Standardization and Application Of Polymerase Chain Reaction (PCR)
    • Immunoglobulin Products
      • Subcutaneous immunoglobulin
      • Normal human immunoglobulin
      • Hyperimmune Immunoglobulin Products
      • Hepatitis B Immunoglobulin
      • Treatment for Chronic Hepatitis B Infection
      • Rh(D) immunoglobulin
      • Tetanus Immunoglobulin
      • Zoster Immunoglobulin
    • Albumin products
    • Clotting Factor and Other Products
      • Factor VIII
      • Factor IX
      • Factor VIIa
      • FEIBA
      • Prothrombin complex
      • Antithrombin III
      • Protein C
      • Fibrogammin
      • Factor XI and Factor XIII
      • C1 Esterase Inhibitor
  • Blood Research And Technology
    • Bovine Serum
    • Genetically Engineered Blood Products
    • Government Regulation
      • United States Government Regulation
      • European Government Regulation
      • Each European Union Member State Has Its Own Procedures for Authorization Of Medicines, Within Its Own Territory,
    • Cord Blood
    • Chinese Serum Contaminated with AIDS Virus
    • Chinese Biological Product Regulations
    • Chinese Drug Industry Under Attack
  • Serum (Blood) Company Profiles
    • ANZCO Foods / Bovogen Biologicals
      • Clients and Suppliers
      • Development and Prospects
      • ANZCO Foods Jointly Owned by Itoham Foods (Mitsubishi Corporation shareholder), Nippon Suisan Kaisha
      • ANZCO Foods Animal Serum Product Sub-Lots
      • ANZCO Foods / Bovogen Biologicals
      • Bovogen Biologicals
      • ANZCO Foods Revenue
    • Ausgenex Pty Ltd
      • AusGeneX Revenue
    • Avantor
      • Avantor / VWR Sole Supplier For Cell And Gene Therapy to Catapult.
      • Avantor / VWR
      • VWR Animal and Human Blood for Use in DNA/RNA Isolation or for Testing Infectious Diseases
      • VWR
      • Avantor Revenue
      • VWR Revenue
      • VMR Plasma-Based Biopharmaceutical Manufacturing Industry in China i
      • VWR Suppliers
    • Biochrom GmbH
    • Biotest AG
    • BPL Group
    • Cellsera Rutherford
      • Cellsera Rutherford Certificates and Accreditations
      • Cellsera Privately owned, 100% Australian company
      • Cellsera Manufacturing Facility
    • Changchun SRbiological
      • Zen Bio Human Serum & Animal-Free Growth Supplement
      • Zen Bio Human Serum Technical Advantage Over Animal Serum
      • Zen-Bio Animal Serum - Cell Culture
    • China Biologic Products
      • China Biologic Sales
      • China Biologic Acquisition TianXinFu
      • China Biologic Products Holdings, Revenue
      • China Biologic Sales Volume Of Products by Segment
      • China Biologic Research And Development Expenses
      • China Biologic Products Holdings, Manufacturing Facilities
      • China Biologic Products Holdings
    • Chinese Plasma Market and Acquisitions
      • Chinese Blood Product Industry
        • Table Blood Plasma and Serum Providers To China, Market Shares, Dollars, Worldwide, 2017
        • Table Blood Plasma and Serum Providers To China Description, 2017
      • In August 2011, China Shut Down 16 Plasma Stations in Guizhou
    • Corning Life Sciences
      • Corning Life Sciences Operation
      • Corning Life Sciences Revenue Structure
        • Table Corning Life Sciences Revenue Structure
      • R&D and Investment
      • Corning Life Sciences Sera Products
      • Corning Cell Growth and Differentiation
      • Corning Cancer Research
      • Corning Cell Culture
      • Custom Media and Sterile Solutions
      • Corning(R) Fetal Bovine Serum
      • Corning Regional Presence
    • Global Cord Blood Corp.
    • CSL
      • CSL 35 Per Cent Annual Growth in Chinese Albumin Sales
      • CSL Bought 80 Per Cent Stake In Chinese Plasma Fractionator Wuhan Zhongyuan Ruide Biologics
      • CSL addresses Market for 100 Million Chinese with Liver Problems
        • Table CSL Behring Sales
    • ExCel Bio
    • GE Healthcare Life Sciences
      • GE HyClone- Fetal Bovine Serum, Standard
      • GE Healthcare HyClone- AdvanceSTEM- ES Qualified Amino Acids
      • GE Healthcare HyClone- Fetal Bovine Serum (Canada), Characterized
      • GE Healthcare HyClone- Fetal Bovine Serum, Super Low IgG
      • GE Healthcare HyClone- Fetal Bovine Serum, Human Mesenchymal Stem Cell Screened
      • GE Healthcare HyClone- Fetal Bovine Serum (New Zealand), Characterized
      • GE Healthcare HyClone- Fetal Bovine Serum, Defined
      • GE Healthcare HyClone- Fetal Bovine Serum, Characterized
      • GE Healthcare HyClone- Fetal Bovine Serum, Tetracycline Screened
      • GE HyClone- Bovine Growth Serum
      • CBMG and GE Healthcare Life Sciences China Partner on CAR T-Cell and Stem Cell Manufacturing
    • Grifols S.A. (GRFS)
      • Grifols U.S. Presence
      • Grifols Revenue
      • Grifols Acquires 24 Plasma Donation Centers in the United States
      • Grifols Plasma Collection
      • Grifols Bioscience Products and Services
    • Hualan Biological Engineering Inc.
    • Kedrion S.p.A.
      • Kedrion Revenue
    • Lake Immunogenics
      • Lake Immunogenics Profile
      • Lake Immunogenics Operation
    • Lanzhou Minhai
    • LFB Biotechnologies
    • Mallinckrodt
    • Merck KGaA / Millipore / Sigma-Aldrich
      • Sigma-Aldrich Cell Cytotoxicity Assay
      • USA Origin, Sterile-Filtered, Suitable For Cell Culture, Suitable For Hybridoma
      • Merck / BioControl Systems
    • Moregate Biotech
    • Newman Biotech
    • Octopharma AG
      • Octapharma R&D and Investment
    • Sanpower Group
    • Selborne Biological Services
      • Selborne Biological Services Animal Blood-Derived Products
      • Selborne Biological Services Plasma
    • Proliant
      • Proliant Can Produce As Much BSA As The World Uses Each Year
      • Proliant Closed-Loop Processing
      • Lauridsen Group / Proliant
    • Shanghai RAAS
      • Shanghai RAAS R&D
      • Shanghai RAAS Revenue
    • Rocky Mountain Biologicals (RMBIO)
      • Rocky Mountain Biologicals Revenue
    • Sanquin
    • Takeda / Shire
      • Shire Pharmaceuticals (SHPG) / Baxalta
      • Shire Revenue
      • Shire Hematology
      • Shire Immunology
      • Shire Neuroscience
      • Shire Lysosomal Storage Diseases
      • Shire Gastrointestinal / Endocrine
      • Shire HAE
      • Shire Ophthalmics
      • Shire / Servier Oncology
      • Takeda / Shire Financial Goals
    • South Pacific Sera
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific Revenues, United States, China, Other, Consolidated revenues
      • Thermo Fisher Scientific Microbiology
      • Thermo Fisher Scientific Serum Preparation
      • Thermo Fisher Scientific Plasma Preparation
      • Thermo Fisher Animal Serum
      • Thermo Fisher Scientific Quality, Performance, And Consistency Essential To Cell Culture
    • Beijing Tiantan Biological Products
      • Tiantan Bio Sales Model
      • Tiantan Bio Management Model
      • Tiantan Bio Profile
      • Tiantan Bio Operation
      • Tiantan Bio Revenue Structure
      • Tiantan Bio R&D and Investment
      • Tiantan Bio Development and Prospects
      • Tiantan Biological Products
      • Beijing Tiantan Biological Products Profile
      • Beijing Tiantan Biological Products
      • Tiantan Bio Cosmetic Serum Market
    • Wuhan Sanli
    • Wolongsong
    • ZenBio
      • ZenBio Human Serum
    • Selected Chinese Blood Companies
      • Global Animal Blood Plasma Products and Derivatives Market
      • Global Bovine Blood Plasma Derivatives Market
      • Blood Serum Industry Key Players.
      • Cosmetic Serum Market
      • Plasma Fractionation Market
  • Winter Green Research,
    • WinterGreen Research Methodology
    • WinterGreen Research Process
    • Market Research Study
    • WinterGreen Research Global Market Intelligence Company

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report